Editas Medicine Inc reports results for the quarter ended in March - Earnings Summary

Editas Medicine

05/05/2023 14:31

* Editas Medicine Inc  EDIT.OQ  reported a quarterly
adjusted loss
of 71 cents​​ per share for the quarter ended in March. The mean
expectation of seventeen analysts for the quarter was for a loss
of 78 cents per share.
    * Revenue rose 45.5% to $9.85 million from a year ago;
analysts
expected $3.01 million. 
    * Editas Medicine Inc's reported EPS for the quarter was a
loss
of 71 cents​.
    * The mean earnings estimate of analysts had risen by
about 33.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Editas Medicine Inc shares had risen by 20.3% this
quarter and
lost 1.7% so far this year.
    * The company reported a quarterly loss of $49.04 million.
    * Wall Street's median 12-month price target for Editas
Medicine
Inc is $12.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 11
"hold" and 3 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.78          -0.71          Beat
 Dec. 31 2022      -0.80          -0.88          Missed
 Sep. 30 2022      -0.87          -0.81          Beat
 Jun. 30 2022      -0.82          -0.78          Beat